Earlier this year, Australian hospital operator Healthscope Ltd said it would sell its Asian pathology business to private equity giant TPG Capital Management LP TPG.UL to cut debt and bankroll growth plans, months after rejecting two buyout approaches. business is tracking ahead of expectations on an year-to-date basis. Terms of the transaction were not disclosed. The TriRx (formerly Endo/Par) Huntsville, Alabama cream and ointment (a. Capital Recovery Group, Federal Equipment Company, Heritage Global Partners, and PPL Group LLC have jointly purchased a pharmaceutical manufacturing and packaging facility from Endo International plc (Endo) in Huntsville, Alabama. The company reaffirmed guidance it announced in November which excludes the impact of the acquisition. CDMOs are a key link in the pharmaceutical supply chain, but most do not meet. Sonic also announced a fully underwritten institutional placement to raise A$600 million ($431.88 million) and a non-underwritten share purchase plan to retail shareholders in Australia and New Zealand to raise up to A$100 million. The acquisition of Aurora is expected to be about three percent EPS accretive post-placement on a pro-forma FY2019 basis before expected revenue and cost synergies, Sonic said in a statement. It follows Eli Lilly's exit from the field earlier this year in the form of a $1.5 billion IPO for its animal health unit, Elanco.Īustralian pathology and radiology group Sonic Healthcare Ltd said on Wednesday it had agreed to buy Florida-based Aurora Diagnostics LLC ADI.UL for $540 million. The deal comes on the heels of Bayer's announcing it will hive off its animal health unit as part of a restructuring to focus in on its pharma business. Consumer products-such as Fitbit-type activity trackers for dogs, microchip-controlled cat doors and feeding systems-are part of the mix, too. 30, a figure Merck can likely pump up through its network of connections with veterinarians and other suppliers. And the privately held, France-based Antelliq brought in about €360 million in sales over the 12 months ended Sept. It's the fastest-growing piece of the animal health market, Merck said in its Friday statement. Endo said other painkillers such as Percocet and Endocet could be made at a. The microchip IDs that pet owners know well are just part of the business, too Antelliq's technology helps farmers track their livestock along their path to market. Endo shares fell 2.2 percent in afternoon trading on Nasdaq, versus a small gain in the S&P Pharmaceuticals Index. The pharma giant is scooping up Antelliq, a company that specializes in digital ID and tracking for livestock and pets, in a deal worth €3.25 billion. is plowing ahead-and in a new market to boot. With a sterile manufacturing facility located in Rochester, Michigan, Par Sterile Products possesses an unparalleled reputation for high-quality products and an impeccable record of regulatory compliance.Bayer may be getting out of the animal health business, but Merck & Co. Par Sterile Products develops, manufactures and markets a broad portfolio of branded and generic aseptic injectable products. Endo Pharmaceutical: The State of Alabama and its subdivisions will receive 25 million this year in a lump-sum payment. Our focus is on therapeutically equivalent ANDA-based products, and others on a case-by-case basis. Par Pharmaceutical specializes in modified-released oral solid dosage forms as well as non-oral dosage forms, such as nasal sprays, inhalers, patches and other alternative drug delivery platforms. We offer high-quality, cost-effective products with the highest level of customer service. Par Pharmaceutical, a wholly owned Endo business, is a highly focused generic pharmaceutical company dedicated to delivering quality medicines to patients in need through excellence in innovation, development, manufacturing, and commercialization.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |